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In this Research Topic of Frontiers in Mucosal Immunology we
have focused on gut IgA B cell responses. We have invited world
leading researchers in the field to contribute with articles that give
the most recent up-date on our current understanding of this
interesting and complex protective system. Because a majority
of all human pathogens access the body via the mucosal mem-
branes we need an effective innate and adaptive immune system
to protect against infectious diseases at these sites. Secretory IgA
(SIgA) antibody formation is a hallmark of this protective barrier
function (1). However, it does not only play a role for protection
against pathogens, it also serves as a key element in establish-
ing stable homeostasis between the host and the microbiota of the
mucosal membranes (2). For example, the gut IgA system develops
after weaning in early life and critically influences the symbiosis
between the host and the commensal bacteria (3, 4). Recent data
suggest that each individual accumulates highly mutated gut IgA
gene sequences over time and that the development of long-term
memory B cells is a cardinal feature of mucosal IgA immunity (5).
This appears to apply not only to B cells responding to T cell-
dependent (TD) antigens, but, in fact, may also apply to B cells
responding to T cell-independent (TI) antigens derived from the
microbiota (6). To explain the high level of mutations in gut IgA
gene sequences in adults it has been proposed that the IgA B cell
inductive sites, primarily the Peyer’s patches (PP), play a major role
in allowing extensive cell division and, hence, promoting multiple
mutations (7). Since mutations are acquired in germinal centers
and these are formed as a consequence of T-B cell cooperation
following antigen stimulation it has become increasingly impor-
tant to understand the fine detail of how germinal centers in the
PP are regulated. A prime question is whether germinal centers
in PP also could host B cells that respond to TI-antigens, which
could then promote cell division and allow for the accumulation
of multiple mutations in differentiating B cells. Recent findings
suggest that activated gut B cells can re-utilize already established
germinal centers in PP and in this way gut SIgA responses can
be synchronized and oligoclonal, securing a high quality of the
protective SIgA antibodies in the lamina propria (8). Based on
these observations the function of follicular helper T cells (TFH)
in PP then appear to be quite unique compared to that found
in peripheral lymph nodes. In fact, failure to develop appropri-
ate TFH (PD-1 deficiency) in PP have been found to drastically
affect the composition of the microbiota, arguing in favor of that
IgA B cell differentiation directly impacts on gut homeostasis and
the presence of certain bacterial species (9). Mice that lack the
ability to mutate IgA B cell responses have been shown to host
bacterial overgrowth in the gut and have a dysfunctional mucosal
barrier in the absence of IgA affinity maturation (10). Impor-
tantly, erroneous activation of the mucosal immune system can
result in chronic inflammation and development of autoimmu-
nity or allergy. Thus, non-responsiveness or immune tolerance, is
critical and a special feature of the regulatory mechanisms that pre-
vail at mucosal immune inductive sites (11). Hence the mucosal
immune system must maintain a finely tuned balance between
tolerance and responsiveness to mucosal antigens, including TI-
antigens derived from the microbiota. As already discussed, this
does not mean that the gut SIgA system is ignorant about the
microbiota, but rather the contrary, that there is a balance in
the adaptive immune response to establish homeostasis and avoid
inflammatory reactions.
A series of review articles, which broadly address the differ-
ent aspects of SIgA and how gut intestinal B cell responses are
generated and regulated, is presented in this Research Topic. The
first article by Knoop and Newberry gives an overview of the gut
mucosal IgA-inductive sites and discusses the role of the vari-
ous inductive tissues; PP, isolated lymphoid follicles (ILF), and
colon patches for normal SIgA homeostasis and what happens
in immune dysfunction. The second review paper by Kunisawa
and Kiyono focuses on the PP as inductive site for SIgA responses
and describes how commensal bacteria can stimulate SIgA, which
then can promote increased up-take of bacteria into the PP tissue
and also how this mechanism can establish intra-PP habitation
of Alcaligenes bacteria, i.e., what are the consequences of hav-
ing an indigenous commensal in PP. Slack, Balmer, Fritz, and
Hapfelmeier then describes in the third review the functional
flexibility of intestinal IgA formation that is also key to under-
standing how symbiosis with the microbiota can be maintained
in the gut. This is also a theme entertained by Corthésy as he
describes the multi-faceted functions of SIgA in the fourth review
paper. Special attention is given to the innate properties of SIgA
as an anti-inflammatory regulator, showing that not only Fab-
specific antigen-recognition contributes to gut homeostasis and
protection against pathogens, but also that SIgA exerts an effect
on epithelial cell integrity and the mucosal barrier functions. The
fifth review paper in this Research Topic explores the different find-
ings of enhanced IgA plasma cell activity in gut lamina propria
of patients with celiac disease, the prototypic gut inflammatory
condition that results from a dysfunctional immune response to
dietary gluten. Especially, Mesin, Sollid, and Di Niro describes
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long-term plasma cell production of autoantibodies in the lam-
ina propria against transglutaminase 2, which may constitute as
many as 4–24% of the total IgA plasma cell population in celiac
lesions. Spencer, Klavinskis, and Fraser continuous on this line of
human immunobiology of the SIgA system and discuss burning
questions relating to how to understand its organization and reg-
ulation in health and disease. In particular, comparisons are made
between what we know about human SIgA immune responses and
the information we have gained from experimental rodent mod-
els. The next review article by Lycke and Bemark addresses how we
can explain the fact that SIgA immune responses to TD-antigens
in the gut are oligoclonal and appear to be synchronized along
the entire small and large intestine. The role of PP in this con-
text is highlighted and regulatory aspects of PP germinal centers
are presented in a challenging theory. Finally, the contribution by
Conner and Blutt describes various functional aspects of gut SIgA
responses against gastrointestinal virus infections and discusses
what we can do to harness the protective properties of SIgA to
achieve better mucosal vaccines.
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